Cosmos HealthCOSM -7.07%29 PS Ratio is 0.09 as of Jun. 27, 2026, which is 90% below its 10-year median of 0.91. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Cosmos Health ranks better than 92.37% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cosmos Health's share price is $0.1722.
Cosmos Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.01. Hence, Cosmos Health's PS Ratio for today is 0.09.
Good Sign:
Cosmos Health Inc stock PS Ratio (=0.09) is close to 2-year low of 0.09.
The historical rank and industry rank for Cosmos Health's PS Ratio or its related term are showing as below:
COSM'
s PS Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.91 Max: 33.52
Current: 0.09
During the past 13 years, Cosmos Health's highest PS Ratio was 33.52. The lowest was 0.03. And the median was 0.91.
COSM's PS Ratio is ranked better than 92.37% of 118
companies
in the Medical Distribution industry
Industry Median: 0.425
vs COSM: 0.09
Cosmos Health Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Cosmos Health was -21.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -56.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -59.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -10.50% per year.
During the past 13 years, Cosmos Health's highest 3-Year average Revenue per Share Growth Rate was 303.10% per year. The lowest was -67.90% per year. And the median was 7.10% per year.
Back to Basics: PS Ratio
Cosmos Health (NAS:COSM) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cosmos Health PS Ratio Related Terms
Cosmos Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Cosmos Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cosmos Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cosmos Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cosmos Health's Share Price of today is $0.1722. Cosmos Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cosmos Health (COSM) has a PS Ratio of 0.09 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cosmos Health and its competitors. This is 90% below median its historical median of 0.91. Over the past decade, Cosmos Health's PS Ratio has ranged from 0.03 to 33.52. According to the industry distribution chart, Cosmos Health ranks #9 out of 118 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is Cosmos Health's PS Ratio too high?
Cosmos Health's current PS Ratio of 0.09 is 90% below median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 33.52. The Medical Distribution industry median PS Ratio is 0.43. Cosmos Health's value of 0.09 is 78.8% below this industry median. Based on the distribution chart, Cosmos Health ranks #9 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's PS Ratio compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #9 out of 118 companies for PS Ratio. This places Cosmos Health in the top 8% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.43. Cosmos Health's value of 0.09 is 78.8% below this benchmark. Historically, Cosmos Health's own PS Ratio has ranged from 0.03 to 33.52 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 0.43, Cosmos Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.43, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current PS Ratio of 0.09 is 78.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current PS Ratio is 0.09, which is 90% below median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.17 — trading 52.2% below its estimated fair value. The current PS Ratio is 0.09, which is 90% below median its 10-year median of 0.91 and 78.8% below the Medical Distribution industry median of 0.43. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cosmos Health (COSM), the current PS Ratio is 0.09 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.17 is trading 52.2% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
PS Ratio: 0.09 (90% below median its 10-year median of 0.91)
GF Value™: $0.36 vs. price of $0.17 (52.2% below fair value)
Industry Position: 78.8% below the Medical Distribution median (#9 of 118)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
